X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adenocarcinoma (3) 3
adult (3) 3
aged (3) 3
cancer therapies (3) 3
chemotherapy (3) 3
female (3) 3
humans (3) 3
index medicus (3) 3
male (3) 3
medical prognosis (3) 3
metastasis (3) 3
middle aged (3) 3
oncology (3) 3
surgery (3) 3
tumors (3) 3
adenocarcinoma - drug therapy (2) 2
adenocarcinoma - pathology (2) 2
anthracyclines (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
cancer (2) 2
carcinoma (2) 2
chemoradiotherapy (2) 2
cisplatin - administration & dosage (2) 2
clinical trials (2) 2
esophageal (2) 2
esophageal cancer (2) 2
gene expression (2) 2
leucovorin (2) 2
leucovorin - administration & dosage (2) 2
metastases (2) 2
pancreatic cancer (2) 2
patients (2) 2
perioperative chemotherapy (2) 2
product development (2) 2
resection (2) 2
stomach cancer (2) 2
stomach neoplasms - drug therapy (2) 2
stomach neoplasms - pathology (2) 2
studies (2) 2
survival (2) 2
toxicity (2) 2
5-methylcytosine (1) 1
abridged index medicus (1) 1
adenocarcinoma - surgery (1) 1
administration, oral (1) 1
aged, 80 and over (1) 1
analysis (1) 1
antigens, neoplasm - genetics (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
arbeitsgemeinschaft internistische onkologie (1) 1
azacitidine - analogs & derivatives (1) 1
azacitidine - pharmacology (1) 1
baldness (1) 1
capecitabine - administration & dosage (1) 1
capecitabine - therapeutic use (1) 1
care and treatment (1) 1
cisplatin (1) 1
cisplatin - therapeutic use (1) 1
classification (1) 1
colorectal-carcinoma (1) 1
confidence intervals (1) 1
control methods (1) 1
culture techniques (1) 1
cytolytic lymphocytes-t (1) 1
dendritic cells (1) 1
deoxyribonucleic acid--dna (1) 1
digestive system surgical procedures (1) 1
disease-free survival (1) 1
dna (1) 1
dna methylation (1) 1
dna modification methylases - antagonists & inhibitors (1) 1
docetaxel (1) 1
docetaxel - administration & dosage (1) 1
docetaxel - therapeutic use (1) 1
dosage and administration (1) 1
drug therapy (1) 1
endoscopy (1) 1
enzyme inhibitors - pharmacology (1) 1
epirubicin (1) 1
epirubicin - administration & dosage (1) 1
esophageal neoplasms - drug therapy (1) 1
esophageal neoplasms - pathology (1) 1
esophageal neoplasms - surgery (1) 1
esophagogastric cancer (1) 1
esophagogastric junction (1) 1
esophagogastric junction - pathology (1) 1
esophagus (1) 1
event-related potentials (1) 1
fluorouracil - administration & dosage (1) 1
fluorouracil - therapeutic use (1) 1
gage (1) 1
gastroenterology & hepatology (1) 1
gemcitabine (1) 1
gene expression regulation (1) 1
hematology, oncology and palliative medicine (1) 1
histology (1) 1
hospital anxiety (1) 1
identification (1) 1
ii trial (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 12, pp. 1697 - 1708
Journal Article
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10184, pp. 1948 - 1957
Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-oesophageal junction adenocarcinoma. This study reports on the safety and efficacy... 
SURGERY | REGRESSION | MEDICINE, GENERAL & INTERNAL | MULTICENTER | RESECTION | CHEMORADIOTHERAPY | OPEN-LABEL | ESOPHAGEAL | CANCER | STOMACH | Capecitabine - administration & dosage | Leucovorin - administration & dosage | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Male | Oxaliplatin - therapeutic use | Stomach Neoplasms - pathology | Cisplatin - administration & dosage | Fluorouracil - therapeutic use | Docetaxel - administration & dosage | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Female | Leucovorin - therapeutic use | Oxaliplatin - administration & dosage | Administration, Oral | Esophagogastric Junction - pathology | Treatment Outcome | Capecitabine - therapeutic use | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Digestive System Surgical Procedures | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Docetaxel - therapeutic use | Aged | Neoplasm Staging | Adenocarcinoma | Anthracyclines | Chemotherapy | Leucovorin | Product development | Esophageal cancer | Cancer | Intravenous administration | Control methods | Toxicity | Clinical trials | Oncology | Metastasis | Cancer therapies | Stomach cancer | Metastases | Confidence intervals | Infusion | Oxaliplatin | Motivation | Surgery | Intravenous infusion | Epirubicin | Medical research | Survival | Patients | Cisplatin | Esophagus | Interactive systems | Medical prognosis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.